1604610

Risedronate sodium

United States Pharmacopeia (USP) Reference Standard

• Synonyme(s) : Risedronic acid monosodium salt hemi(pentahydrate)
• Formule empirique (notation de Hill): C₇H₁₀NNaO₇P₂ · 2.5H₂O
• Numéro CAS: 329003-65-8
• Poids moléculaire : 350.13
• Numéro MDL: MFCD01706268
• Code UNSPSC : 41116107
• Nomenclature NACRES : NA.24

Propriétés

• Qualité: pharmaceutical primary standard
• Famille d'API: risedronate
• Fabricant/nom de marque: USP
• Application(s): pharmaceutical (small molecule)
• Format: neat
• Chaîne SMILES: OP(C(P(O)([O-])=O)(O)CC1=CC=CN=C1)(O)=O.[Na+]
• InChI: 1S/2C7H11NO7P2.2Na.5H2O/c2*9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6;;;;;;;/h2*1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15);;;5*1H2/q;;2*+1;;;;;/p-2
• Clé InChI: HYFDYHPNTXOPPO-UHFFFAOYSA-L

Description

Description générale

Risedronate sodium is a member of the pyridinyl class of bisphosphonates. It is mostly used as an antiresorptive agent. It can be used in treating and preventing postmenopausal and glucocorticoid-induced osteoporosis.

Application

Risedronate sodium USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Risedronate Sodium Tablets
• Risedronate Sodium Delayed-Release Tablets

Remarque sur l'analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Autres remarques

Sales restrictions may apply.

Informations sur la sécurité

• Pictogrammes: GHS08,GHS07
• Mention d'avertissement: Warning
• Mentions de danger: H302,H319,H361,H371
• Conseils de prudence: P202 - P260 - P264 - P301 + P312 - P305 + P351 + P338 - P308 + P311
• Classification des risques: Acute Tox. 4 Oral - Eye Irrit. 2 - Repr. 2 - STOT SE 2
• Code de la classe de stockage: 11 - Combustible Solids
• Classe de danger pour l'eau (WGK): WGK 3
• Point d'éclair (°F): Not applicable
• Point d'éclair (°C): Not applicable